Kish J - Search Results

1

Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.

Tapazoglou E, Kish J, Ensley J, Al-Sarraf M. Tapazoglou E, et al. Among authors: kish j. Am J Clin Oncol. 1988 Aug;11(4):474-8. doi: 10.1097/00000421-198808000-00013. Am J Clin Oncol. 1988. PMID: 3407628

2

Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma.

Al-Kourainy K, Crissman J, Ensley J, Kish J, Kelly J, Al-Sarraf M. Al-Kourainy K, et al. Among authors: kish j. Am J Clin Oncol. 1988 Aug;11(4):427-30. doi: 10.1097/00000421-198808000-00002. Am J Clin Oncol. 1988. PMID: 2457306

3

An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.

Ensley J, Kish J, Tapazoglou E, Jacobs J, Weaver A, Atkinson D, Ahmed K, Mathog R, Al-Sarraf M. Ensley J, et al. Among authors: kish j. J Clin Oncol. 1988 Jul;6(7):1147-53. doi: 10.1200/JCO.1988.6.7.1147. J Clin Oncol. 1988. PMID: 3292714 Clinical Trial.

4

Phase II clinical evaluation of AZQ in renal cell carcinoma.

Decker DA, Kish J, Al-Sarraf M, Goldfarb S. Decker DA, et al. Among authors: kish j. Am J Clin Oncol. 1986 Apr;9(2):126-8. doi: 10.1097/00000421-198604000-00004. Am J Clin Oncol. 1986. PMID: 3717078

5

Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinoma.

Kish JA, Ensley JF, al-Sarraf M. Kish JA, et al. Am J Clin Oncol. 1990 Feb;13(1):17-8. doi: 10.1097/00000421-199002000-00005. Am J Clin Oncol. 1990. PMID: 2305717

6

Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer.

Kish JA, Ensley JF, Jacobs JR, Binns P, al-Sarraf M. Kish JA, et al. Am J Clin Oncol. 1988 Oct;11(5):553-7. doi: 10.1097/00000421-198810000-00009. Am J Clin Oncol. 1988. PMID: 3177258

7

5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.

Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J, Wynne J. Patel B, et al. Among authors: kish j. Am J Med Sci. 1987 Oct;294(4):238-43. doi: 10.1097/00000441-198710000-00004. Am J Med Sci. 1987. PMID: 3661619

8

The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer.

Tapazoglou E, Kish J, Ensley J, Al-Sarraf M. Tapazoglou E, et al. Among authors: kish j. Cancer. 1986 Mar 15;57(6):1105-9. doi: 10.1002/1097-0142(19860315)57:6<1105::aid-cncr2820570607>3.0.co;2-w. Cancer. 1986. PMID: 3943034

9

The Wayne State University experience with adjuvant chemotherapy of head and neck cancer.

al-Sarraf M, Kish JA, Ensley JF. al-Sarraf M, et al. Among authors: kish ja. Hematol Oncol Clin North Am. 1991 Aug;5(4):687-700. Hematol Oncol Clin North Am. 1991. PMID: 1890060 Review.

10

The incidence and significance of thromboembolic complications in patients with high-grade gliomas.

Cheruku R, Tapazoglou E, Ensley J, Kish JA, Cummings GD, al-Sarraf M. Cheruku R, et al. Among authors: kish ja. Cancer. 1991 Dec 15;68(12):2621-4. doi: 10.1002/1097-0142(19911215)68:12<2621::aid-cncr2820681218>3.0.co;2-7. Cancer. 1991. PMID: 1933812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters